Drug and clinical candidate information for grin3b (ChEMBL ID: CHEMBL2094124):

Molecule: ORPHENADRINE CITRATE
ChEMBL ID: CHEMBL1200395
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1959

Molecule: ACAMPROSATE CALCIUM
ChEMBL ID: CHEMBL2068724
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2004

Molecule: AMANTADINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1569
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1968

Molecule: MEMANTINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1699
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003

Molecule: ORPHENADRINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1201023
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1957

Molecule: FELBAMATE
ChEMBL ID: CHEMBL1094
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1993

Molecule: KETAMINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1714
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1970

Molecule: DELUCEMINE
ChEMBL ID: CHEMBL2110814
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AZD8108
ChEMBL ID: CHEMBL3707355
Mechanism of Action: ANTAGONIST
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: LANICEMINE
ChEMBL ID: CHEMBL467084
Mechanism of Action: BLOCKER
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: GW468816
ChEMBL ID: CHEMBL1207366
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: APIMOSTINEL
ChEMBL ID: CHEMBL3989872
Mechanism of Action: PARTIAL AGONIST
Max Phase: 2.0
Molecule Type: Protein

Molecule: RAPASTINEL
ChEMBL ID: CHEMBL3544917
Mechanism of Action: PARTIAL AGONIST
Max Phase: 3.0
Molecule Type: Protein

Molecule: NEBOGLAMINE
ChEMBL ID: CHEMBL1255840
Mechanism of Action: POSITIVE ALLOSTERIC MODULATOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AV-101
ChEMBL ID: CHEMBL3545351
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CNS-5161
ChEMBL ID: CHEMBL41306
Mechanism of Action: BLOCKER
Max Phase: -1.0
Molecule Type: Small molecule

Molecule: INDANTADOL
ChEMBL ID: CHEMBL3707400
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: RALFINAMIDE
ChEMBL ID: CHEMBL2107771
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ESKETAMINE
ChEMBL ID: CHEMBL395091
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: ESKETAMINE HYDROCHLORIDE
ChEMBL ID: CHEMBL2364609
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2019

Molecule: NERAMEXANE MESYLATE
ChEMBL ID: CHEMBL2106798
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: PERZINFOTEL
ChEMBL ID: CHEMBL452461
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule
